Sermorelin.

The TL;DR.

Sermorelin is the first 29 amino acids of the hormone your hypothalamus naturally makes to tell your pituitary to release growth hormone. When you inject it, your pituitary responds the same way it would to your own body's signal — by releasing a pulse of GH. This is fundamentally different from injecting synthetic HGH directly.

With Sermorelin, your body's own feedback system stays in control. If GH goes too high, your hypothalamus releases somatostatin to slow things down. This makes it physiologically harder to overdose than with synthetic HGH. The trade-off is a lower ceiling — you can only get as much GH as your pituitary is capable of making.[3]

How it's actually used.

Before you start

• Draw baseline bloodwork. IGF-1, fasting glucose, HbA1c, fasting insulin, prolactin, cortisol (AM), TSH, free T4. See §8 for the full panel.
• Rule out active malignancy. GH and IGF-1 are mitogenic. Sermorelin is contraindicated in anyone with active or recent cancer without oncologist clearance.
• Confirm pituitary health. Sermorelin works by stimulating the pituitary. Pituitary adenoma or prior pituitary surgery — consult an endocrinologist first.
• Obtain a prescription. Sermorelin requires an Rx in the US. It is not legally sold for human use without one.
• Gather supplies. Bacteriostatic water, 1 mL insulin syringes (29–31 gauge, 5/16" needle), alcohol swabs, sharps container.
• Set a consistent injection time. Bedtime is strongly preferred. GH is naturally pulsed during slow-wave sleep — injecting at bedtime amplifies the largest natural pulse of the day.

Standard dosing

Sigalos et al. (2017) used 100 mcg TID and achieved a 50% IGF-1 increase over 134 days.[4] Community practice has trended toward higher single doses rather than three smaller doses. community

Reconstitution math (injectable)

Sermorelin arrives as lyophilized powder, typically in 2 mg, 5 mg, or 9 mg vials.

Injection site guide

Sermorelin is administered subcutaneously — into the fat layer just beneath the skin, not into muscle. Rotate through:

• Abdomen — 2 inches from the navel, left or right side
• Outer thigh — middle third
• Lateral hip / love-handle area

A 7-site rotation (one per day of the week) is practical for daily dosing. Pinch the skin, insert at 45°, inject slowly, release the pinch before withdrawing.

Missed doses

• Missed by <12 hours: take the dose when you remember, then resume normal schedule.
• Missed by >12 hours: skip the missed dose entirely. Do not double-dose.
• Missed 3+ consecutive days: resume at the starting dose (100 mcg) for 1 week before returning to your usual dose.

Community consensus and real-world experience

In community discussions, the most commonly reported protocol is 200–300 mcg at bedtime, 5–7 nights per week, stacked with Ipamorelin at the same dose. Improved sleep quality is the most-reported first effect (weeks 2–4), followed by improved recovery and modest body composition changes at months 2–4. community Sermorelin alone produces more modest results than a sermorelin + GHRP stack — it is considered the "gentlest" entry point into GH-axis peptides.

What to eat alongside.

Sermorelin elevates GH and IGF-1, both of which promote protein synthesis and lipolysis. Supporting nutrition matters.

Macronutrient adjustments

• Protein: 1.6–2.2 g/kg of body weight per day. IGF-1 drives muscle protein synthesis; adequate protein is required for translation into lean mass. well-established[5]
• Carbohydrates: Avoid large carb meals within 2 hours before injection. Insulin blunts GH release. The bedtime injection should be taken at least 90 minutes after the last meal. well-established[6]
• Fat: No specific restriction. Adequate dietary fat supports hormone production.

Micronutrient adjustments

• Zinc: 15–30 mg/day with food. Required for GH receptor signaling and IGF-1 production. Deficiency impairs response. emerging[7]
• Magnesium: 200–400 mg glycinate or threonate at bedtime. Supports slow-wave sleep architecture — when the largest natural GH pulse occurs. emerging
• Vitamin D: Maintain serum 25-OH vitamin D above 40 ng/mL. Low vitamin D is associated with reduced IGF-1 levels. emerging[8]

Synergistic supplements

• Ipamorelin: 100–300 mcg at same time as Sermorelin. Complementary mechanism (GHRP vs. GHRH) — synergistic GH pulse. community
• Melatonin: 0.5–1 mg, 30 min before bed. Deepens slow-wave sleep, amplifying the nocturnal GH pulse.
• L-Arginine: 3–5 g before bed. Inhibits somatostatin; may slightly enhance GH pulse. emerging
• Glycine: 3 g before bed. Improves sleep quality; may modestly increase GH.

Protective supplements

No specific protective supplements are required at standard doses. If fasting glucose rises above normal (see §8), consider berberine 500 mg with meals as a precaution. community

What can go wrong.

Reported side effects

Drug interactions

• Glucocorticoids (prednisone, dexamethasone) — suppress GH secretion; blunt Sermorelin response. Avoid concurrent use if possible.
• Insulin — hyperinsulinemia suppresses GH release; reduces Sermorelin efficacy. Inject fasted or 90+ min post-meal.
• Aromatase inhibitors — reduce estrogen → reduce IGF-1 expression. Expect blunted IGF-1 gains.[4]
• Synthetic HGH — redundant mechanism; pituitary receptor downregulation risk. Do not combine.
• Somatostatin analogues (octreotide) — directly antagonize Sermorelin's mechanism. Contraindicated.

Contraindications

Red flags

Pregnancy, lactation & fertility

No human data. Animal reproduction studies have not been conducted. Do not use during pregnancy or while breastfeeding. GH and IGF-1 play roles in reproductive function; no clinical data on Sermorelin's effect on fertility in humans.

Theoretical risks

• Long-term pituitary effects. Chronic stimulation of the GHRH receptor over decades is uncharacterized in healthy adults. Whether tolerance, fatigue, or adaptive changes occur is unknown.

What to combine it with.

Anti-pattern stacks — avoid

How to train on it.

Sermorelin produces gradual, subtle effects — not rapid recomposition. Users who expect dramatic changes in 4–8 weeks are typically disappointed.

Expected trajectory

Training adjustments

• Recovery capacity increases modestly. You may tolerate slightly higher training volume — don't dramatically ramp in the first 4 weeks.
• Sleep quality improvement (often the first reported benefit) enhances recovery. Prioritize 7–9 hours.
• Fasted morning training — consider a sermorelin injection 30–60 min before to amplify the GH pulse during exercise. community Advanced protocol.
• Avoid large carb meals within 2 hours before any injection.

Cut / recomp / bulk contexts

• Cut: Supports lean-mass preservation during a caloric deficit. High protein (2.0–2.4 g/kg) + resistance training is essential.
• Recomp: The most commonly reported use case. Gradual lean-mass gain with simultaneous fat loss at maintenance calories.
• Bulk: Less commonly used during aggressive bulking. GH promotes lean mass but also water retention. Some users cycle off during bulks.

How to store it.

Light & freeze sensitivity

• Light — moderately sensitive. Avoid prolonged UV exposure.
• Freeze — do not freeze reconstituted solution. Lyophilized powder can withstand freezing, but refrigeration is preferred.

Travel

• Transport in an insulated cooler bag with ice packs.
• Reconstituted vials should not exceed 4 hours at room temperature in transit.
• Carry in hand luggage — not checked baggage — to avoid temperature extremes.
• Unreconstituted powder is more travel-stable; reconstitute at destination if possible.

Sourcing & legal access

• United States. Rx required. Available from 503A compounding pharmacies with a valid prescription. Not FDA-approved; not legally sold for human use without an Rx.
• Cost-per-cycle (USD). Typically $80–$180 per month at standard dose via US compounding pharmacies.
• Global. UK MHRA: not licensed, may be available as "specials" via specialist prescriber. EU EMA: not approved, varies by member state. Canada: not Health Canada-approved; compounding pharmacy with Rx. Australia: TGA not approved; SAS Category B with prescriber application.

What to track.

Baseline panel

Mid-cycle panel (weeks 6–8)

Post-cycle panel (4 weeks after stopping)

Doctor handoff

vs. similar compounds.

When to pick Sermorelin

Sermorelin is the longest-standing GHRH analogue with the most established safety record. Choose Sermorelin when you want the most physiologically-natural GH pulse pattern and prescription access matters.

When to pick CJC-1295 (No DAC)

Functionally similar to Sermorelin with a slightly longer half-life. Has largely replaced Sermorelin in clinical practice for its longer duration. Pick this if longer per-injection duration matters.

When to pick Tesamorelin

The most-studied GHRH analogue with FDA approval for HIV-associated lipodystrophy. If cost is not a barrier, Tesamorelin is the better-evidenced choice for adults seeking GH-axis support.

When to pick MK-677

Pick MK-677 if oral dosing is preferred. Sermorelin produces a more physiological pulsatile pattern. MK-677 brings significantly more side effects (water retention, hunger, insulin resistance).

What the mechanism looks like.

Mechanism of action

Sermorelin is the biologically active N-terminal fragment (amino acids 1–29) of human GHRH. The full 44-amino-acid GHRH sequence is not required for biological activity; the first 29 residues contain the complete receptor-binding domain.

Sermorelin binds to the GHRH receptor (GHRHR), a G-protein-coupled receptor expressed on somatotroph cells of the anterior pituitary. Binding activates adenylyl cyclase → increases intracellular cAMP → activates protein kinase A → phosphorylates transcription factors → stimulates GH gene transcription and GH secretion. well-established

Sermorelin also stimulates pituitary gene transcription of hGH mRNA, increasing pituitary GH reserve over time — the basis of the "pituitary recrudescence" effect described by Walker (2006).[3] The pituitary becomes more capable of GH production with sustained sermorelin use.

The GH pulse triggered by sermorelin is subject to negative feedback from somatostatin, which is released from the hypothalamus in response to elevated GH and IGF-1. This feedback loop prevents pathological GH excess — a key safety advantage over exogenous HGH.

Pharmacokinetics

Active metabolites

No active metabolites identified. Sermorelin is degraded into inactive amino-acid fragments by plasma peptidases.

Human clinical trials

Adult clinical data is sparse — most published data is pediatric or extrapolated.

Open questions

Frequently asked.

Where it stands, by jurisdiction.

Last verified · May 17, 2026

Is Sermorelin for you?

What we cited.